Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With Cirrhosis
- PMID: 34560279
- DOI: 10.1016/j.cgh.2021.09.023
Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With Cirrhosis
Comment on
-
Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.Clin Gastroenterol Hepatol. 2022 Jun;20(6):1382-1393.e19. doi: 10.1016/j.cgh.2021.07.010. Epub 2021 Jul 10. Clin Gastroenterol Hepatol. 2022. PMID: 34256144 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
